NFKB1 and viral infectious disease: The antiviral effect of IMPDH2 inhibitors is likely through inhibition of NF-κB, supported by our results showing that NF-κB inhibitors, particularly bortezomib, indeed restrict viral infection of SARS-CoV-2 in cell culture as well (Figures 7E–G).